satranidazole has been researched along with azomycin in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (56.52) | 18.7374 |
| 1990's | 3 (13.04) | 18.2507 |
| 2000's | 3 (13.04) | 29.6817 |
| 2010's | 4 (17.39) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arya, VP; George, T; Gowrishankar, R; Nagarajan, K; Nair, MD; Shenoy, SJ; Sudarsanam, V | 1 |
| Jennings, FW | 1 |
| Edwards, DI; Knight, RC; Whitty, P; Zahoor, A | 1 |
| Hof, H; Ströder, J | 1 |
| Gowrishankar, R; Oza, SD; Phadke, RP; Talwalker, S | 1 |
| Acharya, TK; David, J; Grewal, RS; Kaul, CL; Nargunde, HS; Ringe, SY; Wagle, GP | 1 |
| Gangoli, SD; Marathe, MR; Nair, TB; Rao, RR | 1 |
| Bhopale, KK; Chatterjee, DK; Dutta, AK; Nagarajan, K; Ray, DK; Shrivastava, VB; Tendulkar, JS | 1 |
| Datta, AK; Nagarajan, K; Ray, DK; Shrivastava, VB; Tendulkar, JS | 1 |
| Doshi, B; Gadgil, SD; Kulkarni, RD; Talwalkar, S; Vaidya, AB | 1 |
| Mankodi, NA; Paul, T; Ray, DK; Sheth, UK; Vaidya, AB | 1 |
| Bhat, N; Rao, RR | 1 |
| Bhatia, SC; Shanbhag, VD | 1 |
| Chatterjee, DK; Ray, DK; Tendulkar, JS | 1 |
| Nagarajan, K; Ray, DK; Shrivastava, VB; Tendulkar, JS | 1 |
| Bhopale, KK; Kaul, CL; Masani, KB; Pargal, A; Pradhan, KS; Rao, C | 1 |
| Kar, P; Madan, K; Muzaffar, J; Sharma, MP | 1 |
| Ahirwar, M; Gupta, Y; Jain, A; Jain, SK | 1 |
| Bansal, K; Chaturvedi, TP; Jain, A; Rajput, A; Rawat, MK; Singh, S | 1 |
| Kalra, N; Naik, SB; Pradeep, AR; Priyanka, N | 1 |
| Kalra, N; Malgaonkar, N; Nikhil, M; Pradeep, AR; Priyanka, N; Saquib, S; Tarakji, B; Umashree, D; Varsha, J | 1 |
| Dhat, S; Kokare, C; Pund, S; Sharma, P; Shrivastava, B | 2 |
4 trial(s) available for satranidazole and azomycin
| Article | Year |
|---|---|
Satranidazole: experimental evaluation of activity against anaerobic bacteria in vitro and in animal models of anaerobic infection.
Topics: Amebicides; Animals; Bacteria, Anaerobic; Bacterial Infections; Male; Mice; Microbial Sensitivity Tests; Nitroimidazoles; Sepsis | 1985 |
Randomized, single-blind, placebo-controlled multicenter trial to compare the efficacy and safety of metronidazole and satranidazole in patients with amebic liver abscess.
Topics: Adult; Antiprotozoal Agents; Drug Tolerance; Female; Humans; Incidence; Liver Abscess, Amebic; Male; Metronidazole; Middle Aged; Nausea; Nitroimidazoles; Single-Blind Method; Taste Disorders | 2006 |
A randomized controlled clinical trial on the clinical and microbiological efficacy of systemic satranidazole in the treatment of chronic periodontitis.
Topics: Adult; Aggregatibacter actinomycetemcomitans; Anti-Bacterial Agents; Bacterial Load; Bacteroides; Chronic Periodontitis; Combined Modality Therapy; Dental Plaque; Dental Plaque Index; Dental Scaling; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nitroimidazoles; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Placebos; Polymerase Chain Reaction; Porphyromonas gingivalis; Root Planing; Treatment Outcome | 2013 |
Efficacy of Subgingivally Delivered Satranidazole in the Treatment of Type 2 Diabetes Subjects with Chronic Periodontitis: A Randomized Controlled Clinical Trial.
Topics: Administration, Topical; Adult; Anti-Bacterial Agents; Chronic Periodontitis; Combined Modality Therapy; Dental Plaque Index; Dental Scaling; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Follow-Up Studies; Gels; Gingival Crevicular Fluid; Humans; Male; Middle Aged; Nitroimidazoles; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Placebos; Root Planing; Treatment Outcome | 2015 |
19 other study(ies) available for satranidazole and azomycin
| Article | Year |
|---|---|
Nitroimidazoles, Part XXIII--activity of satranidazole series against anaerobic infections.
Topics: Amebicides; Bacteria, Anaerobic; Bacterial Infections; Bacteroides fragilis; Clostridium perfringens; Microbial Sensitivity Tests; Nitroimidazoles; Structure-Activity Relationship | 1992 |
Chemotherapy of CNS-trypanosomiasis: the combined use of the arsenicals and nitro-compounds.
Topics: Animals; Antiprotozoal Agents; Arsenicals; Brain Diseases; Drug Synergism; Drug Therapy, Combination; Female; Ketoconazole; Metronidazole; Mice; Nifurtimox; Nitro Compounds; Nitroimidazoles; Oxidation-Reduction; Suramin; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 1991 |
Satranidazole: mechanism of action on DNA and structure-activity correlations.
Topics: Chromatography; DNA, Bacterial; Escherichia coli; Genes, Bacterial; Nitroimidazoles; Structure-Activity Relationship; Transfection | 1986 |
Antibacterial activity of GO 10213, a nitroimidazole derivative.
Topics: Antitrichomonal Agents; Bacteria; Metronidazole; Microbial Sensitivity Tests; Niridazole; Nitroimidazoles | 1986 |
Pharmacological profile of 1-methylsulphonyl-3-(1-methyl-5-nitro-2-imidazolyl)-2-imidazolidinone (Go-10213), a new antiprotozoal agent, in comparison with metronidazole.
Topics: Animals; Antitrichomonal Agents; Blood Pressure; Cats; Central Nervous System; Dogs; Drug Interactions; Electrocardiography; Electroencephalography; Ethanol; Female; Guinea Pigs; Heart Rate; Hemodynamics; In Vitro Techniques; Macaca mulatta; Male; Mescaline; Metronidazole; Mice; Myocardial Contraction; Nitroimidazoles; Rats | 1985 |
Pre-clinical toxicity studies on the new nitroimidazole 1-methylsulphonyl-3-(1-methyl-5-nitroimidazole-2-yl)-2- imidazolidinone.
Topics: Administration, Oral; Animals; Antiprotozoal Agents; Dogs; Drug Administration Schedule; Female; Guinea Pigs; Lethal Dose 50; Macaca mulatta; Male; Mice; Nervous System Diseases; Nitroimidazoles; Organ Size; Rabbits; Rats; Sex Factors; Species Specificity; Spermatogenesis | 1985 |
Comparative studies on the amoebicidal activity of known 5-nitroimidazole derivatives and CG 10213-Go in golden hamsters, Mesocricetus auratus, infected in the liver or caecum or both with trophozoites of Entamoeba histolytica.
Topics: Amebicides; Animals; Cecal Diseases; Cricetinae; Dysentery, Amebic; Entamoeba histolytica; Female; Liver Abscess, Amebic; Male; Mesocricetus; Metronidazole; Nitroimidazoles | 1983 |
A metronidazole-resistant strain of Trichomonas vaginalis and its sensitivity to Go 10213.
Topics: Animals; Antitrichomonal Agents; Drug Resistance, Microbial; Metronidazole; Mice; Nitroimidazoles; Trichomonas vaginalis | 1984 |
The absence of interaction with alcohol of a new antiprotozoal agent Go. 10213 Cibemone.
Topics: Adult; Antiprotozoal Agents; Blood Pressure; Double-Blind Method; Drug Interactions; Ethanol; Heart Rate; Humans; Male; Middle Aged; Nitroimidazoles; Psychomotor Performance | 1984 |
Phase 1 tolerability and antiamoebic activity studies with 1-methylsulphonyl-3-(1-methyl-5-nitro-2-imidazolyl)-2-imidazolidinone (Go.10213): a new antiprotozoal agent.
Topics: Adolescent; Adult; Aged; Antiprotozoal Agents; Drug Evaluation; Dysentery, Amebic; Humans; Male; Middle Aged; Nitroimidazoles | 1983 |
Evaluation of the teratogenic potential in Ciba-Geigy Go 10213, a new nitroimidazole derivative: 1-methane-sulphonyl-3-(1-methyl-5-nitro-1H-imidazole-2-yl)-2- imidazolidinone, an amoebicide, trichomonicide and giardicide, in giardicide, in rats.
Topics: Abnormalities, Drug-Induced; Amebicides; Animals; Antiprotozoal Agents; Antitrichomonal Agents; Bone and Bones; Female; Giardia; Nitroimidazoles; Pregnancy; Rats; Rats, Inbred Strains | 1983 |
Electron-capture gas chromatographic assays of 5-nitroimidazole class of antimicrobials in blood.
Topics: Antitrichomonal Agents; Chromatography, Gas; Humans; Metronidazole; Nitroimidazoles; Ornidazole; Tinidazole | 1984 |
Comparative efficacy of Go 10213 and some nitroimidazoles against Trichomonas vaginalis and T. Foetus in mice infected subcutaneously.
Topics: Animals; Antitrichomonal Agents; Drug Administration Schedule; Mice; Mice, Inbred Strains; Nitroimidazoles; Trichomonas Infections; Trichomonas vaginalis | 1982 |
Comparative efficacy of metronidazole and another 5-nitroimidazole, CG-10213-Go, in caecal amoebiasis in albino mice (Mus musculus).
Topics: Amebicides; Animals; Cecal Diseases; Dysentery, Amebic; Metronidazole; Mice; Nitroimidazoles | 1982 |
Comparative pharmacokinetics and amoebicidal activity of metronidazole and satranidazole in the golden hamster, Mesocricetus auratus.
Topics: Administration, Oral; Amebicides; Animals; Chromatography, High Pressure Liquid; Cricetinae; Female; Half-Life; Liver; Liver Abscess, Amebic; Mesocricetus; Metronidazole; Nitroimidazoles | 1993 |
Design and development of hydrogel beads for targeted drug delivery to the colon.
Topics: Animals; Chitosan; Colon; Drug Delivery Systems; Hydrogel, Polyethylene Glycol Dimethacrylate; Hydrogen-Ion Concentration; Nitroimidazoles; Polymethacrylic Acids; Rats; Solubility | 2007 |
Development of satranidazole mucoadhesive gel for the treatment of periodontitis.
Topics: Adhesiveness; Adhesives; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Delayed-Action Preparations; Excipients; Female; Gels; Gingiva; Gingivitis; Hardness; Humans; Kinetics; Male; Nitroimidazoles; Periodontitis; Solubility; Young Adult | 2009 |
Mechanistic investigation of biopharmaceutic and pharmacokinetic characteristics of surface engineering of satranidazole nanocrystals.
Topics: Animals; Biopharmaceutics; Chemical Engineering; Chemistry, Pharmaceutical; Male; Nanoparticles; Nitroimidazoles; Particle Size; Rats; Rats, Wistar; Surface Properties | 2016 |
Risk management and statistical multivariate analysis approach for design and optimization of satranidazole nanoparticles.
Topics: Drug Design; Models, Theoretical; Multivariate Analysis; Nanoparticles; Nitroimidazoles; Particle Size; Risk Management | 2017 |